Myanmar Health Sciences Research Journal

Download Citation

REFERENCES

 

1.      Lauer GM & Walker BD. Hepatitis C virus infection (Review). New England Journal of Medicine 2001; 345(1): 41-52.

2.     Wild SH, Roglic G, Green A, Sicree R & King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030 response to Rathman and Giani. Diabetes Care 2004; 27(10): 2569-2569.

3.     Tint Swe Latt, Ko Ko Zaw, Ko Ko, Mya Ohnmar, Moh Moh Hlaing, Ei Sander Oo & Kyaw Myint Myat Thein. Report on National Survey of Diabetes Mellitus and Risk Factors for Non-Communicable Disease in Myanmar in 2014. Naypyitaw, Ministry of Health, November 2015; 1-125.

4.     National Institutes of Health. National Institutes of Health Consensus Development Conference: Statement Management of hepatitis C: 2002-June10-12, 2002. Hepatology 2003; 36(5S1): S1-S2.

5.  ASIAN Scientist. Antiviral therapy for hepatitis C improved diabetes outcomes. [Internet] Available from: http://www. asianscientist.com/2013/12/health/ antiviral-therapy-hep-improved-diabetes-outcomes
2013.

6.       Negro F & Alaei M. Hepatitis C virus and type 2 diabetes (Editorial). World Journal of Gastroenterology 2009; 15(13): 1537-1547.

7.       Memon MS, Arain ZI, Naz F, Zaki M, Kumar S & Burney AA. Prevalence of  type 2 diabetes mellitus in hepatitis C virus infected population: A Southeast Asian study. Journal of Diabetes Research. [Internet] Available from: http:// dx.doi.org/ 10.1155/ 2013/539361.

8.        Lecube A, Hernandez C, Genesca J & Simo R. Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis (Review). American Diabetes Association 2006; 29(5): 1140-114.

9.       Sangiorgio L, Attardo T, Gangemi R, Rubino C, Barone M & Lunetta M. Increased frequency of HCV and HBV infection in type 2 diabetic patients. Diabetes Research and Clinical Practice 2000; 48(2): 147-151.

10.    Han Ni. Hepatitis C virus infection in diabetes mellitus patients at Yangon General Hospital and New Yangon General Hospital. [M. Med.Sc thesis], University of Medicine (1), Yangon, 2007.

11.    Sanyal AJ, Chand N, Comar K & Mishahi  F. Hyperinsulinemia blocks the inhibition of hepatitis C virus (HCV) replication by
interferon: A potential mechanism for failure of interferon therapy in subjects with HCV and nonalcoholic fatty liver disease. Journal of Hepatology 2004; 40: 159A.

12.    Skowronski M, Zozulinska D, Juszczyk J & Wierusz-Wysocka B. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 2006; 29(3): 750.

13.    Knobler H & Schattner A. TNF-α, chronic hepatitis C and diabetes: A novel triad. Inter- national Journal of Medicine 2005; 98(1):
1-6.

14.    American Diabetes Association. Standards of Medical Care in Diabetes - 2016. Journal of Clinical and Applied Research and
Education. Diabetes Care
2016; 39(1): S14.

15.    Rehman GU, Ali M, Shah F, Iqbal A, Ahmad A, Hayat Z, et.al. Prevalence of diabetes type 2 in hepatitis C infected patients in Kpk, Pakistan. Biomed Research International 2017: 2416281.

16.    Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Kawamura Y, et al. Sustained virological response reduces incidence of onset

of  type  2 diabetes  in  chronic  hepatitis  C. Hepatology 2009; 49(3): 739-744.

17.    Imazeki F, Yokosuka O, Fukai K, Kanda T, Kojima H & Saisho H. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients. Liver International 2008; 28(3): 355-362.

18.    Ruhl CE, Menke A, Cowie CC & Everhart JE. Relationship of hepatitis C virus infection with diabetes in the US population. Journal of Hepatology 2014; 60(4): 1139-1149.

19.   Montenegro L, Michina AD, Misciagna G, Guerra V, Stat D & Leo AD. Virus C hepatitis and type 2 diabetes: A cohort study in Southern Italy. American Journal of Gastroenterology 2013; 108(7): 1108-1111.

20.    Desouky DE, Kasemy Z, Abdel-Hamid AE, & Omar MS. Insulin resistance and prediabetes in hepatitis C virus patients. American Journal of the Medical Sciences 2015; 350(2): 77-80.

21.    Narita R, Abe S, Kihara Y, Akiyama T, Tabaru A & Otsuki M. Insulin resistance  and insulin  secretion in  chronic hepatitis
C  virus   infection. Journal   of  Hepatology

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2004; 41(1): 132-138.

22.    Custro N, Carrocio A, Ganci A, Scafidi V, Campagna P, & Di Prima L Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes & Metabolism 2001;
27(4 Pt 1): 476-81.

23.    Wilson C. Hepatitis C infection & type 2
DM in American-Indian women. Diabetes Care 2004; 27(9): 2116-2119.

24.    Elhawary EI, Mahmoud GF, Daly MAE, Mekky FA, Esmat GG & Abdel-Hamid M. Association of HCV with diabetes mellitus: An Egyptian case-control study. Virology Journal 2011; 8: 367.

25.    Chehadeh W, Abdella N, Ben-Nakhi A, Al-Arouj M & Al-Nakib W. Risk factors for the development of diabetes mellitus in chronic hepatitis C virus genotype 4 infection. Journal of Gastroenterology  Hepatology 2009; 24(1): 42-48.

26.    Age of Onset for Type 2 Diabetes: Know Your Risk. Available from: URL: https:// www.healthline.com/health/type-2-diabetes-age-of-onset#overview1.Accessed on 10th November 2017.


Vision : Achieving a healthier nation through application of research findings          Mission Statement : To Develop and promote solutions to the major health problems of Myanmar